Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$88.7M Sell
252,179
-319,966
-56% -$114M 0.22% 103
2025
Q4
$187M Buy
572,145
+86,723
+18% +$27.5M 0.43% 40
2025
Q3
$137M Buy
485,422
+200,290
+70% +$58.1M 0.33% 59
2025
Q2
$79.6M Sell
285,132
-7,212
-2% -$2.04M 0.22% 96
2025
Q1
$91.1M Buy
292,344
+49,909
+21% +$14.7M 0.28% 76
2024
Q4
$63.2M Buy
242,435
+11,056
+5% +$3.28M 0.17% 120
2024
Q3
$74.6M Buy
231,379
+88,554
+62% +$29M 0.23% 89
2024
Q2
$44.6M Sell
142,825
-1,460
-1% -$429K 0.13% 139
2024
Q1
$41M Sell
144,285
-155,888
-52% -$45.6M 0.13% 162
2023
Q4
$86.5M Sell
300,173
-101,405
-25% -$27.6M 0.31% 73
2023
Q3
$108M Buy
401,578
+73,999
+23% +$18.5M 0.44% 48
2023
Q2
$72.7M Sell
327,579
-43,861
-12% -$10.2M 0.3% 74
2023
Q1
$89.8M Buy
371,440
+57,019
+18% +$14M 0.38% 56
2022
Q4
$82.6M Buy
314,421
+23,150
+8% +$6.21M 0.4% 57
2022
Q3
$65.7M Buy
291,271
+10,006
+4% +$2.43M 0.34% 64
2022
Q2
$68.4M Buy
281,265
+134,140
+91% +$32.9M 0.34% 72
2022
Q1
$35.6M Sell
147,125
-41,362
-22% -$9.5M 0.14% 173
2021
Q4
$42.4M Sell
188,487
-9,939
-5% -$2.1M 0.14% 173
2021
Q3
$42.2M Sell
198,426
-220,856
-53% -$50.8M 0.15% 157
2021
Q2
$102M Buy
419,282
+69,732
+20% +$17.2M 0.18% 131
2021
Q1
$87M Sell
349,550
-100,402
-22% -$24M 0.18% 142
2020
Q4
$569M Sell
449,952
-121,962
-21% -$28.1M 0.24% 101
2020
Q3
$145M Buy
571,914
+1,730
+0.3% +$429K 0.43% 52
2020
Q2
$134M Buy
570,184
+327,879
+135% +$74.8M 0.45% 41
2020
Q1
$49.1M Buy
242,305
+70,244
+41% +$15.3M 0.41% 49
2019
Q4
$41.5M Sell
172,061
-13,321
-7% -$2.94M 0.26% 92
2019
Q3
$35.9M Sell
185,382
-39,334
-18% -$7.55M 0.26% 87
2019
Q2
$41.4M Buy
224,716
+55
+0% +$9.85K 0.32% 67
2019
Q1
$42.7M Buy
224,661
+132,026
+143% +$25.2M 0.35% 56
2018
Q4
$18M Sell
92,635
-2,663
-3% -$520K 0.2% 127
2018
Q3
$19.8M Buy
95,298
+1,964
+2% +$387K 0.15% 177
2018
Q2
$17.2M Sell
93,334
-4,090
-4% -$723K 0.15% 184
2018
Q1
$16.6M Sell
97,424
-8,287
-8% -$1.52M 0.15% 174
2017
Q4
$18.4M Sell
105,711
-26,457
-20% -$4.68M 0.16% 168
2017
Q3
$24.6M Sell
132,168
-39,258
-23% -$6.96M 0.22% 115
2017
Q2
$29.5M Sell
171,426
-8,535
-5% -$1.39M 0.29% 92
2017
Q1
$29.5M Sell
179,961
-29,725
-14% -$4.94M 0.27% 86
2016
Q4
$30.7M Sell
209,686
-33,656
-14% -$5.07M 0.3% 72
2016
Q3
$40.6M Buy
243,342
+63,389
+35% +$10.7M 0.48% 48
2016
Q2
$27.4M Buy
179,953
+48,177
+37% +$7.49M 0.39% 58
2016
Q1
$19.8M Sell
131,776
-44,683
-25% -$6.64M 0.33% 67
2015
Q4
$28.6M Buy
176,459
+35,012
+25% +$5.5M 0.53% 35
2015
Q3
$19.6M Sell
141,447
-99,345
-41% -$15.7M 0.39% 59
2015
Q2
$37M Buy
240,792
+143,962
+149% +$23.1M 0.48% 40
2015
Q1
$15.5M Sell
96,830
-139,008
-59% -$21.9M 0.2% 139
2014
Q4
$37.6M Buy
235,838
+161,278
+216% +$25.1M 0.45% 44
2014
Q3
$10.5M Sell
74,560
-245,288
-77% -$32M 0.37% 53
2014
Q2
$37.9M Buy
319,848
+9,419
+3% +$1.09M 0.43% 41
2014
Q1
$38.3M Sell
310,429
-35,054
-10% -$4.25M 0.6% 30
2013
Q4
$39.4M Buy
345,483
+13,756
+4% +$1.56M 0.6% 26
2013
Q3
$37.1M Sell
331,727
-3,050
-0.9% -$331K 0.6% 22
2013
Q2
$33M Buy
+334,777
New +$34.7M 0.61% 24

Other funds holding AMGN

KBC Group's AMGN Position: Q1 2026 in Review

KBC Group reduced its Amgen (AMGN) stake by 56% in Q1 2026, selling an estimated $114M and leaving 252,179 shares worth $88.7M. The position accounts for 0.22% of the portfolio, ranked #103.

KBC Group first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $569M in Q4 2020. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • KBC Group held 252,179 shares of Amgen worth $88.7M as of Q1 2026.
  • KBC Group sold 319,966 Amgen shares in Q1 2026, an estimated $114M.
  • Amgen made up 0.22% of KBC Group's portfolio in Q1 2026, its #103 holding.
  • KBC Group first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • KBC Group's Amgen position peaked at $569M in Q4 2020.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.